Simeon George
QuietNamed in filings at SR OneOn the current fund
- Board seats filed
- 11
Named in filings at SR OneOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Avenzo Therapeutics | Biotech & pharma | September 2022 | None on file |
| Rezo Therapeutics | Biotech & pharma | July 2022 | None on file |
| Simcha Therapeutics Holding Company | Biotech & pharma | August 2021 | None on file |
| ADARx Pharmaceuticals | Biotech & pharma | July 2021 | Bain Capital Life Sciences, TCG Crossover, Vivo Capital |
| TP Therapeutics | Biotech & pharma | October 2018 | Venbio Global Strategic, Vivo Capital |
| CRISPR Therapeutics AG | Biotech & pharma | October 2016 | Versant Venture Capital |
| Principia Biopharma | Biotech & pharma | July 2015 | Samsara Biocapital |
| Auxogyn | Medical devices | March 2015 | Kleiner Perkins, Monograph Capital Partners, Vida Ventures, Westlake Biopartners |
| RUIYI | Biotech & pharma | March 2014 | None on file |
| HTG MOLECULAR DIAGNOSTICS | Biotech & pharma | February 2014 | None on file |
| EFFECTOR THERAPEUTICS | Biotech & pharma | May 2013 | Abingworth Bioventures, Sofinnova Venture Partners, The Column Group, U.S Venture Partners |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Simeon George on the board, based on 11 filed seats with a verified or cited source.